Connectivity Predicts deep brain stimulation outcome in Parkinson disease
- PMID: 28586141
- PMCID: PMC5880678
- DOI: 10.1002/ana.24974
Connectivity Predicts deep brain stimulation outcome in Parkinson disease
Abstract
Objective: The benefit of deep brain stimulation (DBS) for Parkinson disease (PD) may depend on connectivity between the stimulation site and other brain regions, but which regions and whether connectivity can predict outcome in patients remain unknown. Here, we identify the structural and functional connectivity profile of effective DBS to the subthalamic nucleus (STN) and test its ability to predict outcome in an independent cohort.
Methods: A training dataset of 51 PD patients with STN DBS was combined with publicly available human connectome data (diffusion tractography and resting state functional connectivity) to identify connections reliably associated with clinical improvement (motor score of the Unified Parkinson Disease Rating Scale [UPDRS]). This connectivity profile was then used to predict outcome in an independent cohort of 44 patients from a different center.
Results: In the training dataset, connectivity between the DBS electrode and a distributed network of brain regions correlated with clinical response including structural connectivity to supplementary motor area and functional anticorrelation to primary motor cortex (p < 0.001). This same connectivity profile predicted response in an independent patient cohort (p < 0.01). Structural and functional connectivity were independent predictors of clinical improvement (p < 0.001) and estimated response in individual patients with an average error of 15% UPDRS improvement. Results were similar using connectome data from normal subjects or a connectome age, sex, and disease matched to our DBS patients.
Interpretation: Effective STN DBS for PD is associated with a specific connectivity profile that can predict clinical outcome across independent cohorts. This prediction does not require specialized imaging in PD patients themselves. Ann Neurol 2017;82:67-78.
© 2017 American Neurological Association.
Conflict of interest statement
M.R., A.K., R.N., J. Vol., and A.A.K. have business relationships with Medtronics, St Judes, and Boston Scientific, which are makers of DBS devices, but none is related to the current work. M.D.F. has submitted a patent on using connectivity imaging to identify the ideal site for brain stimulation; the processing stream is different from this work.
Figures






Comment in
-
Parkinson disease: Deep brain stimulation - making the right connections.Nat Rev Neurol. 2017 Aug;13(8):450-451. doi: 10.1038/nrneurol.2017.91. Epub 2017 Jun 23. Nat Rev Neurol. 2017. PMID: 28643808 No abstract available.
References
-
- Schuepbach WMM, Rau J, Knudsen K, et al. Neurostimulation for Parkinson’s disease with early motor complications. N Engl J Med. 2013;368:610–622. - PubMed
-
- Lozano AM, Lipsman N. Probing and regulating dysfunctional circuits using deep brain stimulation. Neuron. 2013;77:406–424. - PubMed
-
- Litvak V, Jha A, Eusebio A, et al. Resting oscillatory corticosubthalamic connectivity in patients with Parkinson’s disease. Brain. 2011;134(pt 2):359–374. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical